Published in Law and Health Weekly, October 14th, 2006
Protiva, a private biotechnology company, was spun-out from INEX in 2001 along with certain intellectual property rights relating to gene therapy technology. INEX holds a minority interest in Protiva.
This claim, filed in a California court, appears to be substantively the same as one of the allegations made in the suit filed by Protiva in British Columbia Supreme Court in March 2006. INEX filed a statement of defense and counterclaim against...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.